Composition for treating and preventing benign prostatic hyperplasia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9572858
APP PUB NO 20160250279A1
SERIAL NO

15136353

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a composition for treating and preventing benign prostatic hyperplasia, and a method for treating benign prostatic hyperplasia using same. More specifically, the present invention relates to a composition comprising telomerase-derived peptides for effectively treating and preventing benign prostatic hyperplasia and a method for treating benign prostatic hyperplasia using same. The composition comprising the peptide according to the present invention exhibits excellent effectiveness in treating and preventing benign prostatic hyperplasia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GEMVAX & KAEL CO LTD(TAMNIP-DONG) 1F 58 TECHNO 11-RO YUSEONG-GU DAEJEON 34036 34036
KIM SANG JAE12-1 UNJUNG-RO 113 BEON-GIL BUNDANG-GU SEONGNAM-SI GYEONGGI-DO

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Sang Jae Seoul, KR 67 985

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 21, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00